Open access
610
Views
2
CrossRef citations to date
0
Altmetric
REVIEW
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
James F Donohue1 Division of Pulmonary and Critical Care Medicine, University of North Carolina, School of Medicine, Chapel Hill, NC, USA
https://orcid.org/0000-0002-4439-6866View further author information
Tara Rheault2 Verona Pharma plc, Raleigh, NC, USACorrespondence[email protected]
View further author information
, View further author information
Margot MacDonald-Berko2 Verona Pharma plc, Raleigh, NC, USAView further author information
, Thomas Bengtsson3 Stat Mind AB, Lund, SwedenView further author information
& Kathleen Rickard2 Verona Pharma plc, Raleigh, NC, USA
https://orcid.org/0000-0002-2542-6011View further author information
Pages 1611-1622
|
Received 30 Mar 2023, Accepted 03 Jul 2023, Published online: 28 Jul 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.